GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Total Equity

Accelerated Pharma (Accelerated Pharma) Total Equity : $-6.99 Mil (As of Mar. 2017)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Total Equity?

Accelerated Pharma's total equity for the quarter that ended in Mar. 2017 was $-6.99 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Accelerated Pharma Total Equity Historical Data

The historical data trend for Accelerated Pharma's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Total Equity Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
Total Equity
-0.17 -4.43 -6.40

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Total Equity Get a 7-Day Free Trial - -4.95 -5.79 -6.40 -6.99

Accelerated Pharma Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Accelerated Pharma's Total Equity for the fiscal year that ended in Dec. 2016 is calculated as

Total Equity=Total Assets(Q: Dec. 2016 )-Total Liabilities(Q: Dec. 2016 )
=0.147-6.55
=-6.40

Accelerated Pharma's Total Equity for the quarter that ended in Mar. 2017 is calculated as

Total Equity=Total Assets(Q: Mar. 2017 )-Total Liabilities(Q: Mar. 2017 )
=0.198-7.189
=-6.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accelerated Pharma Total Equity Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Total Equity
Comparable Companies
NUVPF ADMD RSPI YBAO ULUR NRXCF ACUR LBLTF PUFXF BKIT RLMD IGC MYOS CBICF SBFM PVCT AQSZF PTLF AOLS APRI
Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines